Tag: Acquisition
Business & Industry
Biogen to Acquire Apellis for $5.6 Billion in Major Deal
Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc. for $5.6 billion, in a move that significantly expands its presence in immunology and rare...
Business & Industry
Transcend Acquisition Advances Otsuka Neuroplastogen Focus
Japanese pharmaceutical company Otsuka has moved to deepen its presence in the emerging neuroplastogen space through an agreement to acquire Transcend Therapeutics, bringing with...
Business & Industry
Novartis $2bn Excellergy Acquisition Boosts Allergy Pipeline
Novartis has entered into an agreement to acquire biotech firm Excellergy, a move that will bring a next-generation anti-immunoglobulin e (IgE) programme into its...
Press Releases
CVC Welcomes Apollo as Minority Investor in Syntegon: Partnership to Accelerate Next Growth Phase
CVC reaffirms confidence in Syntegon's strategic direction and continued growth potential
Apollo acquires 37% minority stake and adds valuable expertise – particularly to...
News
Bayer-Attralus Diagnostic Tracers Deal Expands Imaging Reach
In order to broaden its portfolio in imaging and cardiovascular medicine, Bayer has agreed to purchase two experimental diagnostic imaging agents from Attralus. The...
Drug Research
Amgen Eyeing Preclinical Blood Cancer Program to Its Skills
Amgen is going ahead and adding Dark Blue to its tapestry, embedding the preclinical blood cancer program of U.K. biotech into its organization.
The California pharma has...
Business & Industry
J&J Acquires Clinical-Stage Biotechnology Firm for $3.05bn
Johnson & Johnson - J&J has completed the acquisition of Halda Therapeutics which is a clinical-stage biotechnology firm for an amount of $3.05bn in cash.
This...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read